Executive Team

Brian Lee, Ph.D.
CEO and Founder

Over 25 years of research and leadership experience in biopharmaceutical R&D, bioprocess scale up, and biomanufacturing with Amgen and Merck.

Erik Wiberg, MBA
Chief Financial Officer

Over 25 years of finance leadership experience in life-science tools and capital equipment companies including Thermo Fisher Scientific, Gyros Protein Technologies, and Resolve Biosciences.

Terrell Mathews
Chief Commercial Officer

Over 20 years of sales and marketing experience as former executive Vice President of Global Sales at Danaher's Molecular Devices and Phenomenex.

Matthew Croughan, Ph.D.
Chief Technical Officer

Over 35 years of bioprocessing experience as former CTO of Sapphire, Director of Amgen Bioprocessing Center at KGI, and Chief Scientist at Genentech.

Nelson Bermudez
Chief Operating Officer

Over 25 years of executive experience directing global operations and external contract manufacturing for biopharmaceutical products at Amgen.

Joe Petrosky
Sr. VP of Global Sales

Over 25 years of sales and customer management experience with biotech and medical products at Charter Medical and Millipore Corporation.

Mark Schneider
Senior VP of Finance & Controller

Over 25 years of accounting and financial management experience in biopharmaceutical companies including Amgen, Kythera, and Sienna.

Michael Murguia
VP of Human Resources

Over 35 years of HR management expertise such as talent acquisition, organizational development, and strategic planning at Amgen and various Fortune 100 companies.

Peter Kim, MBA
VP of Marketing

Over 20 years of marketing leadership experience in life science, genomics and high-tech including Vice President of Global Marketing at Danaher’s Phenomenex and Integrated DNA Technologies.

Board of Directors

Brian Lee, Ph.D.
Chairman of the Board, CEO and Founder of PBS Biotech.
Dennis Fenton, Ph.D.
Former Executive VP at Amgen.
Leland Foster, Ph.D.
Former CEO Fisher Scientific Biosciences and Chief Scientist ThermoFisher Scientific.
Jerry Liao
Principal at Avego Management.
Daniel Friedman
Principal at BroadOak Capital Partners.

Advisory Board

Steve Lam
Former VP and General Manager of Single-Use Technology at Thermo Fisher Scientific and VP of Operations at Amgen.
Susan Lundeen
Former VP of Human Resources at Amgen and Kythera Biopharmaceuticals.
Bryan Poltilove
Former Operating Partner at BroadOak Capital and former VP at Thermo Fisher Scientific.
B.G. Rhee, Ph.D.
Chairman and CEO of G.I. Innovations; former Chairman of Korea's Council for Advanced Regenerative Medicine.
Bill Rich
Former VP of Device Technologies, VP of External Supply, and VP of International Supply Chain at Amgen.
Martin Simonetti
Former President & CEO of VLST, CFO of Dendreon, and VP of Finance of Amgen.